Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

REMODULIN DIN 02246552

Status: Marketed
Holder: UNITED THERAPEUTICS CORPORATION
Molecule: TREPROSTINIL (TREPROSTINIL SODIUM)

Health Canada record

Active ingredient(s)TREPROSTINIL (TREPROSTINIL SODIUM) 1 MG
Dosage formSolution
RouteSubcutaneous; Intravenous
SchedulePRESCRIPTION
ClassHuman
ATCB01AC21 TREPROSTINIL
Original market date30-Apr-2004
Current status date07-Oct-2005
SourceHealth Canada DPD

Establishment licence of the holder

United Therapeutics Corporation — licence , not currently licensed, last inspection rating C (2025-04-08).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing TREPROSTINIL (TREPROSTINIL SODIUM)

DINProductCompanyFormStrengthStatus
02246553REMODULINUNITED THERAPEUTICS CORPORATIONSolutionTREPROSTINIL (TREPROSTINIL SODIUM) 2.5 MGMarketed
02246554REMODULINUNITED THERAPEUTICS CORPORATIONSolutionTREPROSTINIL (TREPROSTINIL SODIUM) 5 MGMarketed
02246555REMODULINUNITED THERAPEUTICS CORPORATIONSolutionTREPROSTINIL (TREPROSTINIL SODIUM) 10 MGMarketed
02523841TREPROSTINIL INJECTIONDR REDDY'S LABORATORIES LTDSolutionTREPROSTINIL (TREPROSTINIL SODIUM) 1 MGApproved
02523868TREPROSTINIL INJECTIONDR REDDY'S LABORATORIES LTDSolutionTREPROSTINIL (TREPROSTINIL SODIUM) 2.5 MGApproved
02523876TREPROSTINIL INJECTIONDR REDDY'S LABORATORIES LTDSolutionTREPROSTINIL (TREPROSTINIL SODIUM) 5 MGApproved
02523884TREPROSTINIL INJECTIONDR REDDY'S LABORATORIES LTDSolutionTREPROSTINIL (TREPROSTINIL SODIUM) 10 MGApproved
02561700TREPROSTINIL INJECTIONMARCAN PHARMACEUTICALS INCSolutionTREPROSTINIL (TREPROSTINIL SODIUM) 1 MGApproved
02561719TREPROSTINIL INJECTIONMARCAN PHARMACEUTICALS INCSolutionTREPROSTINIL (TREPROSTINIL SODIUM) 2.5 MGApproved
02561727TREPROSTINIL INJECTIONMARCAN PHARMACEUTICALS INCSolutionTREPROSTINIL (TREPROSTINIL SODIUM) 5 MGApproved
02561735TREPROSTINIL INJECTIONMARCAN PHARMACEUTICALS INCSolutionTREPROSTINIL (TREPROSTINIL SODIUM) 10 MGApproved

Notices of Compliance

NOCDateSubmissionReason
75332005-10-06Supplement to a New Drug Submission (SNDS)NEW ROUTE OF ADMINISTRATION - INTRAVENOUS
8332002-10-04New Drug Submission (NDS)
Request a quote for REMODULIN

How to read a Canadian DIN record